PUBLISHER: The Business Research Company | PRODUCT CODE: 1946937
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946937
Pediatric neurology devices are medical instruments specifically designed to aid in the diagnosis, prevention, and treatment of various neurological disorders in children. These devices are utilized by pediatric neurologists and other medical professionals to address the complete spectrum of neurological disorders in pediatric patients.
The primary types of pediatric neurology devices include neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Neurostimulation devices are medical equipment that alters the activity of the nervous system through electrical or magnetic stimulation. They are employed in the treatment of various conditions such as stroke, seizures, hydrocephalus, and oncology. The range of services and treatments associated with these devices includes electroencephalogram, intrathecal baclofen therapy, neurological evaluations, vagal nerve stimulation, among others. These devices are utilized by various end users, including hospitals, ambulatory surgery centers, and other healthcare facilities.
Tariffs are impacting the pediatric neurology device market by increasing import costs for precision electronics, imaging hardware, neurostimulation components, and catheter-based interventional systems, which has raised manufacturing and procurement expenses across neurostimulation, neurosurgery, interventional neurology, and csf management segments. The effects are more pronounced in North America, Europe, and Asia-Pacific markets that depend on cross-border sourcing for pediatric eeg systems, shunts, navigation platforms, and vascular intervention devices used in hospitals and ambulatory surgery centers. These higher landed costs have contributed to pricing pressure and delayed equipment upgrades in cost-sensitive facilities; however, tariffs are also encouraging regional assembly, localized supplier ecosystems, and strategic partnerships that support selective positive outcomes for domestic production capabilities.
The pediatric neurology device market research report is one of a series of new reports from The Business Research Company that provides pediatric neurology device market statistics, including pediatric neurology device industry global market size, regional shares, competitors with a pediatric neurology device market share, detailed pediatric neurology device market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric neurology device industry. This pediatric neurology device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pediatric neurology device market size has grown strongly in recent years. It will grow from $2.65 billion in 2025 to $2.8 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to rising incidence of pediatric neurological disorders and developmental conditions, growing availability of eeg and neurodiagnostic assessment services, early adoption of neurosurgery and csf shunt procedures in tertiary hospitals, expansion of pediatric stroke and seizure management programs, increasing investment in pediatric neurology infrastructure in specialty centers.
The pediatric neurology device market size is expected to see strong growth in the next few years. It will grow to $3.45 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growing demand for neurostimulation and vagal nerve stimulation therapies in children, rising utilization of interventional neurology devices for minimally invasive treatment, increasing procedure volumes for hydrocephalus and oncology-related neurology care, expanding access to pediatric neurology services in emerging regions, rising focus on early diagnosis and long-term neurological outcome improvement. Major trends in the forecast period include rising adoption of advanced neurostimulation and neuromodulation devices in pediatric neurology, increasing utilization of interventional neurology devices for complex pediatric stroke and vascular disorders, growing preference for minimally invasive neurosurgical and navigation-assisted procedures, expansion of pediatric cerebrospinal fluid management solutions for hydrocephalus care, increasing use of pediatric eeg monitoring and neurodiagnostic systems in clinical evaluation.
The anticipated increase in the prevalence of autism in children is expected to drive the growth of the pediatric neurology devices market. Autism, a developmental condition affecting how individuals perceive and interact with others, presents challenges in communication and social interaction. Pediatric neurology devices play a crucial role in the diagnosis and treatment of children with autism, contributing to improvements in their quality of life, social skills, and management of cognitive and behavioral symptoms. In March 2023, data from the Centers for Disease Control and Prevention (CDC) revealed that, according to the Autism and Developmental Disabilities Monitoring (ADDM) Network, one in 36 (2.8%) 8-year-old children in 11 communities across the United States were identified with autism spectrum disorder (ASD). Consequently, the rising prevalence of autism in children is a key factor driving the growth of the pediatric neurology devices market.
The rising number of pediatric patients is expected to drive the growth of the pediatric neurology device market in the coming years. A pediatric patient is defined as a minor, generally under the age of 15 or 21, depending on national regulations. Pediatric neurology devices are specifically developed to address the distinct requirements of infants, children, and adolescents, whose neurological systems are still in critical stages of growth and development. Pediatric neurology devices support the diagnosis and management of a range of neurological conditions in children, including stroke, seizures, hydrocephalus, and pediatric oncology. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based intergovernmental organization, the number of children under the age of 18 in care increased to 71 per 100,000 in 2023, compared to 70 per 100,000 in 2022. During the same year, rates were significantly higher among older children, reaching 168 per 100,000 for those aged 16-17 and 76 per 100,000 for children aged 10-15. Therefore, the growing pediatric population is contributing to the expansion of the pediatric neurology device market.
Major companies operating in the pediatric neurology market are prioritizing technological advancements, such as AI-enabled, point-of-care EEG systems, to support rapid identification and diagnosis of electrographic seizures in children, enabling timely clinical intervention and improved neurological outcomes. AI-powered point-of-care EEG systems combine real-time signal processing, algorithm-driven seizure detection, and user-friendly headband designs to deliver actionable bedside insights, helping clinicians reduce treatment delays and lower the risk of brain injury in pediatric patients. For instance, in April 2025, Ceribell, Inc., a US-based medical technology company, obtained FDA clearance for its Clarity algorithm for patients aged 1 year and older. When used with Ceribell EEG headbands, the algorithm enables fast bedside detection of non-convulsive seizures in children, addresses the widest pediatric age range covered by seizure detection technology to date, and utilizes EEG data from more than 1,700 pediatric patients to provide dependable, real-time diagnostic support in emergency and critical care environments.
Major companies operating in the pediatric neurology device market are Johnson & Johnson Co, Abbott Laboratories, Medtronic Plc, Siemens Healthineers AG, Koninklijke Philips NV, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Masimo Corporation, KARL STORZ SE & Co. KG, Nihon Kohden Corporation, Integra LifeSciences Holdings Corp., Elekta AB, LivaNova PLC, Natus Medical Incorporated, Allengers Medical Systems Limited, Compumedics Limited, Cadwell Industries Inc., Spiegelberg GmbH & Co. KG
North America was the largest region in the pediatric neurology device market in 2025. The regions covered in the pediatric neurology device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pediatric neurology device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pediatric neurology device market consists of sales of portable and wearable neurology devices, intracranial pressure (ICP) monitors, cerebral oximeters, and infusion pumps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pediatric Neurology Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pediatric neurology device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pediatric neurology device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric neurology device market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.